Inhibition of mitophagy increases the level of PINK1-mediated phosphorylated TP53, which translocates to the nucleus to suppress NANOG expression, thereby preventing the transition from benign to malignant liver tumors (Qian et al., 2018). The gene discussed is TP53; the disease is liver cancer.